Workflow
德展健康(000813) - 2022 Q3 - 季度财报

Revenue and Profit - Revenue for Q3 2022 was ¥112,623,101.08, a decrease of 6.96% compared to the same period last year[7] - Net profit attributable to shareholders was ¥612,034.46, down 97.20% year-on-year[7] - Net profit excluding non-recurring items was ¥948,951.65, an increase of 101.14% compared to the same period last year[7] - The total operating revenue for the third quarter was CNY 416,621,519.95, a decrease of 18.7% compared to CNY 512,869,188.98 in the same period last year[25] - Net profit attributable to shareholders of the parent company was 66,124,087.08, down 46.8% from 124,478,367.92 in the previous period[30] - The total comprehensive income attributable to the parent company's owners was 66,124,087.08, down 46.8% from 124,478,367.92 in the previous period[30] Assets and Liabilities - Total assets at the end of Q3 2022 were ¥5,702,722,433.80, a decrease of 1.30% from the end of the previous year[7] - The total assets decreased to CNY 5,702,722,433.80 from CNY 5,778,043,347.05, indicating a decline of about 1.3%[25] - Total liabilities decreased to CNY 217,072,988.13 from CNY 308,053,292.52, a reduction of approximately 29.5%[25] - Current assets increased to CNY 3,948,414,682.03, up from CNY 3,562,755,881.68, representing an increase of approximately 10.8%[25] - Non-current assets decreased significantly from CNY 2,215,287,465.37 to CNY 1,754,307,751.77, a decline of about 20.8%[25] Cash Flow - Cash flow from operating activities for the year-to-date was ¥113,120,482.14, down 10.13% year-on-year[7] - Cash flow from operating activities generated a net amount of 113,120,482.14, compared to 125,866,421.66 in the previous period, reflecting a decrease of 10.9%[34] - The company’s cash flow from investing activities showed a significant increase of 405.81% to ¥731,792,248.94 year-to-date[12] - Cash inflow from investment activities was 856,255,077.50, an increase of 33.2% from 642,790,495.59 in the previous period[34] - The net increase in cash and cash equivalents for the period was $815,392,038.50, compared to a decrease of $586,647,367.44 in the previous period[37] Shareholder Information - The total number of common shareholders at the end of the reporting period is 45,982[15] - The largest shareholder, Meilin Holdings Group, holds 19.60% of shares, totaling 437,527,456 shares[15] - The company has a significant number of pledged shares, with 3,580,000 shares pledged by Meilin Holdings Group[15] - The company has a total of 12,961,858 shares held in margin trading accounts[15] Expenses and Impairments - R&D expenses decreased by 34.73% to ¥33,896,459.56 compared to the same period last year[12] - Research and development expenses decreased to 33,896,459.56, a reduction of 34.7% from 51,929,287.83 in the previous period[28] - The company recognized an asset impairment provision of ¥12,759,700 for accounts receivable and inventory as of June 30, 2022[18] - The financial expenses showed a net income of -45,905,976.69, an increase in costs compared to -35,546,929.06 in the previous period[28] Other Significant Events - The company reported a significant decrease in government subsidies received, down 71.79% to ¥1,916,022.89 year-to-date[12] - The company experienced a 32.34% reduction in accounts receivable, totaling ¥215,699,610.89[12] - The company reported a cash balance of ¥2,303,363,501.74 as of September 30, 2022, compared to ¥1,473,720,797.44 on January 1, 2022[19] - The company repurchased 4,100,301 shares, representing 0.18% of the total share capital, at a total cost of ¥13,625,626.32[18] - The company plans to cancel 6,393,668 restricted shares from the first phase of the 2020 equity incentive plan[18] - The company has received regulatory documents from the Xinjiang Securities Regulatory Bureau regarding administrative supervision measures[18] - The company has signed a settlement agreement related to a contract dispute to protect its interests[18] - The third quarter report was not audited, indicating that the financial results are preliminary and subject to change[38]